Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01740076 · ClinicalTrials.gov registry record · NA

Soy Nuts and Cardiovascular Risk in Postmenopausal Women

A NA study of Postmenopausal Women, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT01740076 is a NA study of Postmenopausal Women that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 84 participants, roughly in line with the 80-participant average among 4 other Postmenopausal Women trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01740076, a NA study of Postmenopausal Women, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

To determine the effect of a whole soy food, dietary soy nuts, on blood pressure, lipid levels, inflammation and menopausal symptoms in postmenopausal women.

Conditions Studied

Interventions

  • OTHER soy nuts

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2001-09
Est. Completion 2012-11
Phase NA

What the Registry Record Tells You About NCT01740076

The ClinicalTrials.gov registry entry for NCT01740076 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 80-participant average among 4 other Postmenopausal Women trials with a reported enrollment target. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postmenopausal Women appearing as the primary indexed condition, and to 1 intervention - of which soy nuts is the first listed.

NCT01740076 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01740076 about?

NCT01740076 is a clinical study titled "Soy Nuts and Cardiovascular Risk in Postmenopausal Women". To determine the effect of a whole soy food, dietary soy nuts, on blood pressure, lipid levels, inflammation and menopausal symptoms in postmenopausal women.

What is the current status of trial NCT01740076?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2001-09. Estimated completion is 2012-11.

What conditions does trial NCT01740076 study?

This clinical trial studies the following conditions: Postmenopausal Women.

What interventions are being tested in trial NCT01740076?

The interventions under investigation include: soy nuts (OTHER).

Who is sponsoring clinical trial NCT01740076?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01740076 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postmenopausal Women

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.